Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Early use of renin–angiotensin–aldosterone system inhibitors after renal transplantation

Nature Clinical Practice Nephrology volume 4, pages 306–307 (2008)Cite this article

Jennings DL and Taber DJ (2008) Use of renin–angiotensin–aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Ann Pharmacother 42: 116–120

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nankivell BJ et al. (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326–2333

    Article  CAS  Google Scholar 

  2. Shihab FS et al. (1997) Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52: 660–673

    Article  CAS  Google Scholar 

  3. Dragun D et al. (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352: 558–569

    Article  CAS  Google Scholar 

  4. Hiremath S et al. (2007) Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 7: 2350–2360

    Article  CAS  Google Scholar 

  5. Knoll GA et al. (2008) The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation—study design. Nephrol Dial Transplant 23: 354–358

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Locum Editor, Nature Clinical Practice.

Author information

Author notes

  1. Nephrology, Dialysis and Renal Transplantation Department, University Hospital of Saint-Etienne, Jean Monnet University, 42055 Saint-Etienne, France christophe.mariat@univ-st-etienne.fr

Authors and Affiliations

  1. C Mariat is an Assistant Professor at the University Hospital of Saint-Etienne, Jean Monnet University, Saint-Etienne, France.,

    Christophe Mariat

Authors
  1. Christophe Mariat
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mariat, C. Early use of renin–angiotensin–aldosterone system inhibitors after renal transplantation. Nat Rev Nephrol 4, 306–307 (2008). https://doi.org/10.1038/ncpneph0808

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0808

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing